RAPP
Rapport Therapeutics, Inc.
27.02
+1.06 (+4.08%)
52w low 22.06
52.93 high
16.1% of range
Financial Analysis
| (USD) | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|
| Operating Cash Flow | -27.18M | -64.83M | -87.47M | |
| Depreciation & Amort | 112.00K | 839.00K | 1.02M | |
| Capital Expenditure | -1.64M | -2.40M | -616.00K | |
| Free Cash Flow | -28.82M | -67.23M | -88.09M | |
| Investing Cash Flow | -78.86M | -170.14M | -187.47M | |
| Financing Cash Flow | 145.14M | 221.62M | 270.79M | |
| Share Buybacks | -4.00K | 0.00 | -1.00K |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--